These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 11466819)
21. Ophthalmologic evaluation in patients undergoing immunization with melanoma-associated antigens. Kim CJ; Chan CC; Rosenberg SA J Immunother; 1999 Mar; 22(2):182-3. PubMed ID: 10093043 [No Abstract] [Full Text] [Related]
22. Heterogeneous expression of melanoma-associated antigens and HLA-A2 in metastatic melanoma in vivo. Cormier JN; Hijazi YM; Abati A; Fetsch P; Bettinotti M; Steinberg SM; Rosenberg SA; Marincola FM Int J Cancer; 1998 Feb; 75(4):517-24. PubMed ID: 9466650 [TBL] [Abstract][Full Text] [Related]
23. Intratumoral T-cell infiltrates and MHC class I expression in patients with stage IV melanoma. Al-Batran SE; Rafiyan MR; Atmaca A; Neumann A; Karbach J; Bender A; Weidmann E; Altmannsberger HM; Knuth A; Jäger E Cancer Res; 2005 May; 65(9):3937-41. PubMed ID: 15867394 [TBL] [Abstract][Full Text] [Related]
24. Novel approach to the characterization of melanoma associated-peptide-specific CTL lines from Japanese metastatic melanoma patients. Akiyama Y; Maruyama K; Tai S; Takikawa M; Ohshita C; Yamamoto A; Yamazaki N; Kiyohara Y; Yamaguchi K Int J Oncol; 2008 Sep; 33(3):433-41. PubMed ID: 18695871 [TBL] [Abstract][Full Text] [Related]
25. Comparison of the binding parameters to melanoma cells of antihuman high molecular weight-melanoma associated antigen (HMW-MAA) monoclonal antibodies (mAb) and syngeneic anti-anti-idiotypic (anti-anti-id) mAb. Chen ZJ; Ferrone S Ann N Y Acad Sci; 1993 Aug; 690():398-401. PubMed ID: 8368768 [No Abstract] [Full Text] [Related]
26. Desmoplastic malignant melanoma (a rare variant of spindle cell melanoma). Conley J; Lattes R; Orr W Cancer; 1971 Oct; 28(4):914-36. PubMed ID: 5286448 [No Abstract] [Full Text] [Related]
27. Evaluation of the use of tyrosinase-specific and melanA/MART-1-specific reverse transcriptase-coupled--polymerase chain reaction to detect melanoma cells in peripheral blood samples from 299 patients with malignant melanoma. Brownbridge GG; Gold J; Edward M; MacKie RM Br J Dermatol; 2001 Feb; 144(2):279-87. PubMed ID: 11251559 [TBL] [Abstract][Full Text] [Related]
28. Primary melanoma tumour regression associated with an immune response to the tumour-associated antigen melan-A/MART-1. Saleh FH; Crotty KA; Hersey P; Menzies SW Int J Cancer; 2001 Nov; 94(4):551-7. PubMed ID: 11745443 [TBL] [Abstract][Full Text] [Related]
29. Analysis of the NIH workshop monoclonal antibodies to human melanoma antigens. Kantor RR; Ng AK; Giacomini P; Ferrone S Hybridoma; 1982; 1(4):473-82. PubMed ID: 6208142 [TBL] [Abstract][Full Text] [Related]
30. Direct injection of protamine-protected mRNA: results of a phase 1/2 vaccination trial in metastatic melanoma patients. Weide B; Pascolo S; Scheel B; Derhovanessian E; Pflugfelder A; Eigentler TK; Pawelec G; Hoerr I; Rammensee HG; Garbe C J Immunother; 2009 Jun; 32(5):498-507. PubMed ID: 19609242 [TBL] [Abstract][Full Text] [Related]
31. Single-step antigen loading and activation of dendritic cells by mRNA electroporation for the purpose of therapeutic vaccination in melanoma patients. Bonehill A; Van Nuffel AM; Corthals J; Tuyaerts S; Heirman C; François V; Colau D; van der Bruggen P; Neyns B; Thielemans K Clin Cancer Res; 2009 May; 15(10):3366-75. PubMed ID: 19417017 [TBL] [Abstract][Full Text] [Related]
32. Monoclonal antibodies to 125 kd and 95 kd proteins on human melanoma cells: comparison with other monoclonal-defined melanoma antigens. Saxton RE; Mann BD; Morton DL; Burk MW Hybridoma; 1982; 1(4):433-45. PubMed ID: 6208138 [TBL] [Abstract][Full Text] [Related]
33. Expansion of tumor-T cell pairs from fine needle aspirates of melanoma metastases. Panelli MC; Riker A; Kammula U; Wang E; Lee KH; Rosenberg SA; Marincola FM J Immunol; 2000 Jan; 164(1):495-504. PubMed ID: 10605047 [TBL] [Abstract][Full Text] [Related]
35. Immunocytochemical detection of MART-1 in fresh and paraffin-embedded malignant melanomas. Fetsch PA; Cormier J; Hijazi YM J Immunother; 1997 Jan; 20(1):60-4. PubMed ID: 9101414 [TBL] [Abstract][Full Text] [Related]
36. Identification of a new oncofoetal antigen associated with several types of human carcinomas. Fritsché R; Mach J Nature; 1975 Dec; 258(5537):734-7. PubMed ID: 1207757 [No Abstract] [Full Text] [Related]
37. Stimulation of CD8+ T cell responses to MAGE-3 and Melan A/MART-1 by immunization to a polyvalent melanoma vaccine. Reynolds SR; Oratz R; Shapiro RL; Hao P; Yun Z; Fotino M; Vukmanović S; Bystryn JC Int J Cancer; 1997 Sep; 72(6):972-6. PubMed ID: 9378560 [TBL] [Abstract][Full Text] [Related]
38. The role of fine-needle aspiration cytology in the evaluation of metastatic clear cell tumors. Hughes JH; Jensen CS; Donnelly AD; Cohen MB; Silverman JF; Geisinger KR; Raab SS Cancer; 1999 Dec; 87(6):380-9. PubMed ID: 10603192 [TBL] [Abstract][Full Text] [Related]
39. Identification and isolation of melanoma-associated antigens with monoclonal antibodies. Ross AH; Mitchell KF; Steplewski Z; Koprowski H Hybridoma; 1982; 1(4):413-21. PubMed ID: 6765324 [TBL] [Abstract][Full Text] [Related]